Callan Family Office’s Labcorp LH Stock Holding History

Callan Family Office’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$506K	Buy	1,809 +471	+35%	+$124K	0.01%	809
2026 Q1	$357K	Sell	1,338 -65	-5%	-$17.6K	0.01%	872
2025 Q4	$352K	Buy	1,403 +263	+23%	+$69.8K	0.01%	879
2025 Q3	$327K	Sell	1,140 -281	-20%	-$75.3K	0.01%	677
2025 Q2	$373K	Buy	+1,421	New	+$346K	0.01%	697

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Callan Family Office's LH Position: Q2 2026 in Review

Callan Family Office increased its Labcorp (LH) stake by 35% in Q2 2026, buying an estimated $124K and bringing the position to 1,809 shares worth $506K. The position accounts for 0.01% of the portfolio, ranked #809.

Callan Family Office first reported a position in LH in Q2 2025 and has held it in 5 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Callan Family Office held 1,809 shares of Labcorp worth $506K as of Q2 2026.
Callan Family Office bought 471 Labcorp shares in Q2 2026, an estimated $124K.
Labcorp made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #809 holding.
Callan Family Office first reported a position in Labcorp in Q2 2025 and has held it in 5 quarters since.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.